BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23882990)

  • 1. The cardiology and endocrinology connection between amiodarone and thyrotoxicosis: case report and review of the literature.
    Palermo-Garófalo C; Martínez JH; Silva F; González E; Torres O; Figueroa J; González J; de Lourdes MM
    Bol Asoc Med P R; 2013; 105(2):47-53. PubMed ID: 23882990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
    Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
    Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
    Dietlein M; Schicha H
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone and the thyroid.
    Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating amiodarone-induced thyrotoxicosis with radioactive iodine.
    Iskandar SB; Jordan RM; Peiris AN
    Tenn Med; 2004 Sep; 97(9):408-10. PubMed ID: 15497570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A rare cause of thyreotoxicosis].
    Sauer-Schulz A; Müssig K; Kurth R; Fend F; Teichmann R; Schnauder G
    Dtsch Med Wochenschr; 2010 Sep; 135(37):1798. PubMed ID: 20824601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Challenges in the management of amiodarone-induced thyrotoxicosis].
    Tauveron I; Batisse-Lignier M; Maqdasy S
    Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-induced thyroid dysfunction in clinical practice.
    Ursella S; Testa A; Mazzone M; Gentiloni Silveri N
    Eur Rev Med Pharmacol Sci; 2006; 10(5):269-78. PubMed ID: 17121321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amiodarone-induced thyrotoxicosis].
    Bogazzi F; Tomisti L; Di Bello V; Martino E
    G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amiodarone treatment and thyroid disorders].
    Łacka K; Fraczek MM
    Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.